Exagen Inc. (XGN) Misses Q3 EPS by 15c

Exagen Inc. (NASDAQ: XGN) reported Q3 EPS of ($0.31), $0.15 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $17.24 million versus the consensus estimate of $16.9 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Macquarie Downgrades Luk Fook Holdings International Ltd. (590:HK) (LKFLF) to Neutral
• Tractor Supply and Starlink team up to expand rural broadband via 4-H